
Tiffany A. Traina, MD
Breast Oncologist
Titles
Vice Chair of Outpatient Operations, Department of Medicine; Section Head, Triple Negative Breast Cancer Clinical Research Program
Clinical Expertise
Breast Cancer
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Traina accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-888-5209 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Weill Cornell Medical College
Residencies
Internal Medicine - New York Presbyterian/Weill Cornell Medical Center; Internal Medicine - Memorial Sloan Kettering Cancer Center
Fellowships
Internal Medicine - Memorial Sloan Kettering Cancer Center; Medical Oncology/Hematology - Memorial Sloan Kettering Cancer Center; Internal Medicine - New York Presbyterian/Weill Cornell Medical Center
Board Certifications
Internal Medicine; Medical Oncology
I am a board-certified medical oncologist whose clinical practice is dedicated exclusively to the care of patients with all stages of breast cancer. I am part of a large, multidisciplinary team of devoted specialists who share my goal of providing exceptional care to patients fighting breast cancer. Through my research activities, I work to develop new therapeutic options for the treatment of breast cancer and to ultimately eradicate this disease.
Read more
My research has centered on the use of novel, targeted therapies for the treatment of triple negative breast cancer (TNBC). Currently, I am the lead investigator for a multicenter trial studying the use of androgen receptor inhibition for patients with advanced TNBC. I have investigated numerous other targets for treatment of this subtype of breast cancer, including src and PARP, and have collaborated to develop biologic predictors of response to conventional therapies such as platinum. I have also had a special interest in optimizing drug delivery schedules to minimize side effects of treatment while maximizing its benefits.
I have received grant support for my work from the Breast Cancer Alliance and the Translational Breast Cancer Research Consortium (TBCRC) — a nationwide panel of centers of excellence in breast cancer medicine — where I also serve on the Triple Negative Breast Cancer working group panel. I have lectured internationally and presented our research findings at forums including the annual San Antonio Breast Cancer Symposium and the annual meeting of the American Society of Clinical Oncology (ASCO). I am a member of the New York Metropolitan Breast Cancer Group and serve on the editorial board of the European Journal of Clinical & Medical Oncology. Additionally, I am an ad hoc reviewer for several clinical journals and have published in scientific journals including the Journal of Clinical Oncology and Clinical Cancer Research.
I am committed to providing compassionate care to my patients as they undergo treatment for their breast cancer.
Awards and Honors
- Fellow, American Society of Clinical Oncology (2023)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Nicole M. DeVine. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.
Clinical Trials
- Clinical Trials Investigated by Dr. Traina
- A Phase III Study of Datopotamab Deruxtecan Versus Standard Chemotherapy as Initial Treatment for People with Inoperable or Metastatic Triple-Negative Breast Cancer Who Cannot Have Immunotherapy
- Clinical Trials Co-Investigated by Dr. Traina
- A Phase 1 Study of XMT-1660 in People with Advanced Solid Tumors (Triple-Negative Breast Cancer)
- A Phase II Study of Evexomostat plus Eribulin for People with Triple-Negative Breast Cancer
- A Phase II Study of Olaparib in Patients with Metastatic Breast Cancer with Certain Genetic Mutations

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Traina’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tiffany A. Traina discloses the following relationships and financial interests:
-
AstraZeneca
Provision of Services -
Blueprint Medicines
Provision of Services -
Curio Science LLC
Provision of Services -
Daiichi Sankyo
Provision of Services -
Ellipses Pharma
Provision of Services -
FUJIFILM Pharmaceuticals U.S.A., Inc.
Provision of Services -
Gilead Pharmaceutical
Provision of Services -
IntrinsiQ
Provision of Services
-
Iteos Therapeutics
Provision of Services -
Medscape
Provision of Services -
Merck & Co Inc.
Provision of Services -
Physicians' Education Resource
Provision of Services -
Research to Practice
Provision of Services -
Roche
Provision of Services -
Seattle Genetics
Provision of Services -
Total Health Conferencing
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].